DOI: 10.1055/s-00023610

Drug Research



U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER)
Guidance for Industry Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling. May 2003 Clinical Pharmacology.

Bibliographische Angaben herunterladen

Suchen in: